1 Kalilani L, Asgharnejad M, Palokangas T, Durgin T. Comparing the Incidence of Falls/Fractures in Parkinson's Disease Patients in the US Population. PLoS One. 2016;11(9). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008740

2 Broen MP, Braaksma MM, Patijn J, Weber WE. Prevalence of pain in Parkinson's disease: a systematic review using the modified QUADAS tool. Mov Disord. 2012;27(4):480-484. https://pubmed.ncbi.nlm.nih.gov/22231908

3 Chaudhuri KR, Healy DG, Schapira AH; National Institute for Clinical Excellence. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006;5(3):235-245. https://pubmed.ncbi.nlm.nih.gov/16488379

4 Lieberman A. Depression in Parkinson's disease -- a review. Acta Neurol Scand. 2006;113(1):1-8. https://pubmed.ncbi.nlm.nih.gov/16367891

5 Haehner A, Boesveldt S, Berendse HW, et al. Prevalence of smell loss in Parkinson's disease--a multicenter study. Parkinsonism Relat Disord. 2009;15(7):490-494. https://pubmed.ncbi.nlm.nih.gov/19138875

6 Kashihara K, Hanaoka A, Imamura T. Frequency and characteristics of taste impairment in patients with Parkinson's disease: results of a clinical interview. Intern Med. 2011;50(20):2311-2315. https://pubmed.ncbi.nlm.nih.gov/22001456

7 Bollu PC, Sahota P. Sleep and Parkinson Disease. Mo Med. 2017;114(5):381-386. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140184

8 Yu QJ, Yu SY, Zuo LJ, et al. Parkinson disease with constipation: clinical features and relevant factors. Sci Rep. 2018;8(1):567. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766597

9 Sakakibara R, Shinotoh H, Uchiyama T, et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci. 2001;92(1-2):76-85. https://pubmed.ncbi.nlm.nih.gov/11570707; Sakakibara R, Uchiyama T, Yamanishi T, Kishi M. Genitourinary dysfunction in Parkinson's disease. Mov Disord. 2010;25(1):2-12. https://onlinelibrary.wiley.com/doi/full/10.1002/mds.22519

10 Cummings JL. Intellectual impairment in Parkinson's disease: clinical, pathologic, and biochemical correlates. J Geriatr Psychiatry Neurol. 1988;1(1):24-36. https://pubmed.ncbi.nlm.nih.gov/2908099

11 Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003;60(3):387-392. https://jamanetwork.com/journals/jamaneurology/fullarticle/783882

12 Willis AW, Schootman M, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Predictors of survival in patients with Parkinson disease. Arch Neurol. 2012;69(5):601-607. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599783

13 Savica R, Grossardt BR, Rocca WA, Bower JH. Parkinson disease with and without Dementia: A prevalence study and future projections. Mov Disord. 2018;33(4):537-543. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892791

14 Pennington S, Snell K, Lee M, Walker R. The cause of death in idiopathic Parkinson's disease. Parkinsonism Relat Disord. 2010;16(7):434-437. https://pubmed.ncbi.nlm.nih.gov/20570207; Chang YP, Yang CJ, Hu KF, et al. Risk factors for pneumonia among patients with Parkinson's disease: a Taiwan nationwide population-based study. Neuropsychiatr Dis Treat. 2016;12:1037-1046. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854270

15 Eisenhofer G, Aneman A, Friberg P, et al. Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab. 1997;82(11):3864-3871. https://academic.oup.com/jcem/article/82/11/3864/2866142

16 Hilton D, Stephens M, Kirk L, et al. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Acta Neuropathol. 2014;127(2):235-241. https://pubmed.ncbi.nlm.nih.gov/24240814

17 Del Rey NL, Quiroga-Varela A, Garbayo E, et al. Advances in Parkinson's Disease: 200 Years Later. Front Neuroanat. 2018;12:113. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306622

18 Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583-1590. https://pubmed.ncbi.nlm.nih.gov/24976103

19 Geciteerd op ParkinsonNet: https://www.parkinsonnet.nl/nieuws/parkinson-treft-ook-jonge-mensen

20 Tanner CM, Ottman R, Goldman SM, et al. Parkinson disease in twins: an etiologic study. JAMA. 1999;281(4):341-346. https://jamanetwork.com/journals/jama/fullarticle/188406

21 Sveinbjörnsdottir S, Hicks AA, Jonsson T, et al. Familial aggregation of Parkinson's disease in Iceland. N Engl J Med. 2000;343(24):1765-1770. https://www.nejm.org/doi/full/10.1056/NEJM200012143432404

22 Wirdefeldt K, Gatz M, Reynolds CA, Prescott CA, Pedersen NL. Heritability of Parkinson disease in Swedish twins: a longitudinal study. Neurobiol Aging. 2011;32(10):1923.e1-1923.e19238. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452894

23 Landrigan PJ, Sonawane B, Butler RN, Trasande L, Callan R, Droller D. Early environmental origins of neurodegenerative disease in later life. Environ Health Perspect. 2005;113(9):1230-1233. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1280407

24 Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol. 2011;26 Suppl 1:S1-S58. https://www.researchgate.net/publication/51178448_Epidemiology_and_etiology_of_Parkinson's_disease_A_review_of_the_evidence

25 Chin-Chan M, Navarro-Yepes J, Quintanilla-Vega B. Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front Cell Neurosci. 2015;9:124. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392704

26 Logroscino G. The role of early life environmental risk factors in Parkinson disease: what is the evidence?. Environ Health Perspect. 2005;113(9):1234-1238. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1280408

27 Weisskopf MG, Knekt P, O'Reilly EJ, et al. Persistent organochlorine pesticides in serum and risk of Parkinson disease. Neurology. 2010;74(13):1055-1061. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848105

28 McCormack AL, Thiruchelvam M, Manning-Bog AB, et al. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis. 2002;10(2):119-127. https://pubmed.ncbi.nlm.nih.gov/12127150

29 Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J Neurosci. 2000;20(24):9207-9214. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773035

30 Petrovitch H, Ross GW, Abbott RD, et al. Plantation work and risk of Parkinson disease in a population-based longitudinal study. Arch Neurol. 2002;59(11):1787-1792. https://jamanetwork.com/journals/jamaneurology/fullarticle/783097

31 Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS. Environmental risk factors and Parkinson's disease: a metaanalysis. Environ Res. 2001;86(2):122-127. https://pubmed.ncbi.nlm.nih.gov/11437458/

32 Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, Richardson RJ. Neurology Mar 1997, 48 (3) 650-658; https://n.neurology.org/content/48/3/650

33 Sasco AJ, Paffenbarger RS Jr. Measles infection and Parkinson's disease. Am J Epidemiol. 1985;122(6):1017-1031. https://pubmed.ncbi.nlm.nih.gov/4061437

34 Martyn CN, Osmond C. Parkinson's disease and the environment in early life. J Neurol Sci. 1995;132(2):201-206. https://pubmed.ncbi.nlm.nih.gov/8543949

35 Shen CH, Chou CH, Liu FC, et al. Association Between Tuberculosis and Parkinson Disease: A Nationwide, Population-Based Cohort Study. Medicine (Baltimore). 2016;95(8):e2883. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779022

36 Wang H, Liu X, Tan C, et al. Bacterial, viral, and fungal infection-related risk of Parkinson's disease: Meta-analysis of cohort and case-control studies. Brain Behav. 2020;10(3):e01549. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066372

37 Nam GE, Kim SM, Han K, et al. Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study. PLoS Med. 2018;15(8):e1002640. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103502

38 Yang YW, Hsieh TF, Li CI, et al. Increased risk of Parkinson disease with diabetes mellitus in a population-based study. Medicine (Baltimore). 2017;96(3):e5921. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279101

39 Palacios N, Gao X, McCullough ML, et al. Obesity, diabetes, and risk of Parkinson's disease. Mov Disord. 2011;26(12):2253-2259. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627531

40 Yue X, Li H, Yan H, Zhang P, Chang L, Li T. Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies. Medicine (Baltimore). 2016;95(18):e3549. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863785

41 Sergi D, Renaud J, Simola N, Martinoli MG. Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences. Front Aging Neurosci. 2019;11:302. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856011

42 Iranzo A, Molinuevo JL, Santamaría J, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol. 2006;5(7):572-577. https://pubmed.ncbi.nlm.nih.gov/16781987

43 Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. 2009;72(15):1296-1300. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828948

44 Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;62(5):436-446. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC486843

45 Berendse HW, Booij J, Francot CM, et al. Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol. 2001;50(1):34-41. https://pubmed.ncbi.nlm.nih.gov/11456307

46 Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters ECh, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol. 2004;56(2):173-181. https://pubmed.ncbi.nlm.nih.gov/15293269

47 Ponsen MM, Stoffers D, Wolters EC, Booij J, Berendse HW. Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry. 2010;81(4):396-399. https://jnnp.bmj.com/content/81/4/396

48 Fullard ME, Morley JF, Duda JE. Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease. Neurosci Bull. 2017;33(5):515-525. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636737; Kim JK. Can Olfactory Tests Help to Diagnose Parkinson Disease?. Clin Exp Otorhinolaryngol. 2019;12(2):105-106. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453797

49 Videnovic A, Klerman EB, Wang W, Marconi A, Kuhta T, Zee PC. Timed Light Therapy for Sleep and Daytime Sleepiness Associated With Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 2017;74(4):411-418. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470356

50 Lee SH, Lim S. Clinical effectiveness of acupuncture on Parkinson disease: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2017;96(3):e5836. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279085

51 Cruickshank TM, Reyes AR, Ziman MR. A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease. Medicine (Baltimore). 2015;94(4):e411. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602948

52 Kwok JYY, Kwan JCY, Auyeung M, et al. Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People With Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 2019;76(7):755-763. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583059

53 Angelopoulou E, Anagnostouli M, Chrousos GP, Bougea A. Massage therapy as a complementary treatment for Parkinson's disease: A Systematic Literature Review. Complement Ther Med. 2020;49:102340. https://www.sciencedirect.com/science/article/abs/pii/S0965229919319272?via%3Dihub

54 Haaxma CA, Borm GF, van der Linden D, Kappelle AC, Bloem BR. Artistic occupations are associated with a reduced risk of Parkinson's disease. J Neurol. 2015;262(9):2171-2176. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768224

55 Pohl P, Wressle E, Lundin F, Enthoven P, Dizdar N. Group-based music intervention in Parkinson's disease - findings from a mixed-methods study. Clin Rehabil. 2020;34(4):533-544. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132435

56 McNeely ME, Duncan RP, Earhart GM. A comparison of dance interventions in people with Parkinson disease and older adults. Maturitas. 2015;81(1):10-16. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497370

57 McNeely ME, Duncan RP, Earhart GM. Impacts of dance on non-motor symptoms, participation, and quality of life in Parkinson disease and healthy older adults. Maturitas. 2015;82(4):336-341. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648639

58 Lötzke D, Ostermann T, Büssing A. Argentine tango in Parkinson disease--a systematic review and meta-analysis. BMC Neurol. 2015;15:226. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636067

59 Foster ER, Golden L, Duncan RP, Earhart GM. Community-based Argentine tango dance program is associated with increased activity participation among individuals with Parkinson's disease. Arch Phys Med Rehabil. 2013;94(2):240-249. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557593

60 Choi HJ. Effects of therapeutic Tai chi on functional fitness and activities of daily living in patients with Parkinson disease. J Exerc Rehabil. 2016;12(5):499-503. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091069

61 Xu Q, Park Y, Huang X, et al. Physical activities and future risk of Parkinson disease. Neurology. 2010;75(4):341-348. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918886

62 Fang X, Han D, Cheng Q, et al. Association of Levels of Physical Activity With Risk of Parkinson Disease: A Systematic Review and Meta-analysis. JAMA Netw Open. 2018;1(5):e182421. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324511

63 Cusso ME, Donald KJ, Khoo TK. The Impact of Physical Activity on Non-Motor Symptoms in Parkinson's Disease: A Systematic Review. Front Med (Lausanne). 2016;3:35. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987718

64 Wu PL, Lee M, Huang TT. Effectiveness of physical activity on patients with depression and Parkinson's disease: A systematic review. PLoS One. 2017;12(7):e0181515. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531507

65 Corcos DM, Robichaud JA, David FJ, et al. A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease. Mov Disord. 2013;28(9):1230-1240. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701730

66 Li FJ, Ji HF, Shen L. A meta-analysis of tea drinking and risk of Parkinson's disease. ScientificWorldJournal. 2012;2012:923464. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289976

67 Hernán MA, Takkouche B, Caamaño-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol. 2002;52(3):276-284. https://pubmed.ncbi.nlm.nih.gov/12205639

68 Fujimaki M, Saiki S, Li Y, et al. Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease. Neurology. 2018;90(5):e404-e411. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791797

69 Ishihara L, Brayne C. A systematic review of nutritional risk factors of Parkinson's disease. Nutr Res Rev. 2005;18(2):259-282. https://pubmed.ncbi.nlm.nih.gov/19079910

70 Palacios N, Gao X, O'Reilly E, et al. Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women. Mov Disord. 2012;27(8):980-987. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548327

71 Kim IY, Yang TO, Heath AK, et al. Alcohol intake and Parkinson's disease risk in the million women study. Mov Disord. 2020;35(3):443-449. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155013

72 Lotan I, Treves TA, Roditi Y, Djaldetti R. Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study. Clin Neuropharmacol. 2014;37(2):41-44. https://pubmed.ncbi.nlm.nih.gov/24614667

73 Lastres-Becker I, Molina-Holgado F, Ramos JA, Mechoulam R, Fernández-Ruiz J. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease. Neurobiol Dis. 2005;19(1-2):96-107. https://www.sciencedirect.com/science/article/abs/pii/S0969996104002827

74 Russo EB. Cannabis Therapeutics and the Future of Neurology. Front Integr Neurosci. 2018;12:51. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200872

75 Gallo V, Vineis P, Cancellieri M, et al. Exploring causality of the association between smoking and Parkinson's disease. Int J Epidemiol. 2019;48(3):912-925. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659366

76 Yang F, Pedersen NL, Ye W, et al. Moist smokeless tobacco (Snus) use and risk of Parkinson's disease. Int J Epidemiol. 2017;46(3):872-880. https://academic.oup.com/ije/article/46/3/872/2656164

77 Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol. 2011;26 Suppl 1:S1-S58. https://www.researchgate.net/publication/51178448_Epidemiology_and_etiology_of_Parkinson's_disease_A_review_of_the_evidence

78 Ma C, Liu Y, Neumann S, Gao X. Nicotine from cigarette smoking and diet and Parkinson disease: a review. Transl Neurodegener. 2017;6:18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494127

79 Gao X, Chen H, Fung TT, et al. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr. 2007;86(5):1486-1494. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225168

80 Alcalay RN, Gu Y, Mejia-Santana H, Cote L, Marder KS, Scarmeas N. The association between Mediterranean diet adherence and Parkinson's disease. Mov Disord. 2012;27(6):771-774. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349773

81 Phillips MCL, Murtagh DKJ, Gilbertson LJ, Asztely FJS, Lynch CDP. Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial [published correction appears in Mov Disord. 2019 Jan;34(1):157]. Mov Disord. 2018;33(8):1306-1314.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175383

82 Mischley LK, Lau RC, Bennett RD. Role of Diet and Nutritional Supplements in Parkinson's Disease Progression. Oxid Med Cell Longev. 2017;2017:6405278. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610862

83 Kyrozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopoulos D, Trichopoulou A. Dietary and lifestyle variables in relation to incidence of Parkinson's disease in Greece. Eur J Epidemiol. 2013;28(1):67-77. https://pubmed.ncbi.nlm.nih.gov/23377703

84 Hughes KC, Gao X, Kim IY, et al. Intake of dairy foods and risk of Parkinson disease. Neurology. 2017;89(1):46-52. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496517

85 Chen H, Zhang SM, Hernán MA, Willett WC, Ascherio A. Diet and Parkinson's disease: a potential role of dairy products in men. Ann Neurol. 2002;52(6):793-801. https://pubmed.ncbi.nlm.nih.gov/12447934

86 Miyake Y, Tanaka K, Fukushima W, et al. Lack of association of dairy food, calcium, and vitamin D intake with the risk of Parkinson's disease: a case-control study in Japan. Parkinsonism Relat Disord. 2011;17(2):112-116. https://pubmed.ncbi.nlm.nih.gov/21169048

87 Lister T. Nutrition and Lifestyle Interventions for Managing Parkinson's Disease: A Narrative Review. J Mov Disord. 2020;13(2):97-104. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280935

88 Zhao X, Zhang M, Li C, Jiang X, Su Y, Zhang Y. Benefits of Vitamins in the Treatment of Parkinson's Disease. Oxid Med Cell Longev. 2019;2019:9426867. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402202

89 Ding H, Dhima K, Lockhart KC, et al. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology. 2013;81(17):1531-1537. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888173

90 Evatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V. Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol. 2008;65(10):1348-1352. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746037

91 Kenborg L, Lassen CF, Ritz B, et al. Outdoor work and risk for Parkinson's disease: a population-based case-control study. Occup Environ Med. 2011;68(4):273-278. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667158

92 Luthra NS, Kim S, Zhang Y, Christine CW; NINDS NET-PD Investigators. Characterization of vitamin D supplementation and clinical outcomes in a large cohort of early Parkinson's disease. J Clin Mov Disord. 2018;5:7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208018

93 Fullard ME, Duda JE. A Review of the Relationship Between Vitamin D and Parkinson Disease Symptoms. Front Neurol. 2020;11:454. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267215

94 Etminan M, Gill SS, Samii A. Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis. Lancet Neurol. 2005;4(6):362-365. https://pubmed.ncbi.nlm.nih.gov/15907740; Miyake Y, Fukushima W, Tanaka K, et al. Dietary intake of antioxidant vitamins and risk of Parkinson's disease: a case-control study in Japan. Eur J Neurol. 2011;18(1):106-113. https://pubmed.ncbi.nlm.nih.gov/20491891

95 Yang F, Wolk A, Håkansson N, Pedersen NL, Wirdefeldt K. Dietary antioxidants and risk of Parkinson's disease in two population-based cohorts. Mov Disord. 2017;32(11):1631-1636. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698752

96 Zhao X, Zhang M, Li C, Jiang X, Su Y, Zhang Y. Benefits of Vitamins in the Treatment of Parkinson's Disease. Oxid Med Cell Longev. 2019;2019:9426867. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402202

97 Hellenbrand W, Boeing H, Robra BP, et al. Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology. 1996;47(3):644-650. https://pubmed.ncbi.nlm.nih.gov/8797457

98 Murakami K, Miyake Y, Sasaki S, et al. Dietary intake of folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson's disease: a case-control study in Japan. Br J Nutr. 2010;104(5):757-764. https://pubmed.ncbi.nlm.nih.gov/20338075; Shen L. Associations between B Vitamins and Parkinson's Disease. Nutrients. 2015;7(9):7197-7208. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586528

99 Chen H, Zhang SM, Schwarzschild MA, et al. Folate intake and risk of Parkinson's disease. Am J Epidemiol. 2004;160(4):368-375. https://academic.oup.com/aje/article/160/4/368/165854

100 Costantini A, Pala MI, Compagnoni L, Colangeli M. High-dose thiamine as initial treatment for Parkinson's disease. BMJ Case Rep. 2013;2013:bcr2013009289. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762356

101 Miyake Y, Fukushima W, Tanaka K, et al. Dietary intake of antioxidant vitamins and risk of Parkinson's disease: a case-control study in Japan. Eur J Neurol. 2011;18(1):106-113. https://pubmed.ncbi.nlm.nih.gov/20491891; Yang F, Wolk A, Håkansson N, Pedersen NL, Wirdefeldt K. Dietary antioxidants and risk of Parkinson's disease in two population-based cohorts. Mov Disord. 2017;32(11):1631-1636. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698752

102 Etminan M, Gill SS, Samii A. Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis. Lancet Neurol. 2005;4(6):362-365. https://pubmed.ncbi.nlm.nih.gov/15907740